,
your personalized virtual assistant to find clinical trials. Go head, 
Jonathan Bernstein
University of Cincinnati Division of ...Cincinnati, Ohio - 45267 (513-558-0924) Bernstein Allergy GroupCincinnati, Ohio - 45231 (513-931-0775) Department of Internal Medicine, University ...Cincinnati, Ohio - 45267-0563 (513-235-7971) Univeristy HospitalCincinnati, Ohio - 45219 (513-558-0924) |
- CLINICAL TRIALS 4
- CONDITIONS3
- INTERVENTIONS4
- SINCE2006
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
June 2009 - December 2011
Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
November 2006 - December 2009
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
February 2010 - February 2014
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
May 2010 - December 2011
Angioedema
Angioedema, Hereditary
Rhinitis
Placebo
Montelukast
Icatibant
Ecallantide - Kallikrein Inhibitor That Blocks The Production Of Bradykinin
